Before traveling abroad, contact your destination country's customs office and the local embassy to confirm whether compounded semaglutide is permitted
Lilly's retatrutide delivered up to 24% weight loss in phase 2 obesity study
Participants were randomized in a 1:1:2 ratio to receive once-weekly retatrutide 9 mg, retatrutide 12 mg, or placebo for 80 weeks, with treatment initiated at 2 mg and gradually escalated every four weeks to the assigned maintenance dose
For many patients, there is a transition: Phase 1: Correct Improve insulin resistance Reduce inflammation Initiate weight loss Phase 2: Stabilize Support muscle and metabolism Begin lowering the dose Phase 3: Maintain / Optimize Lower-dose or microdosing approach (when appropriate) Focus on long-term metabolic health At lower doses, GLP-1 medications may continue to support the bodynot just for weight loss, but for overall metabolic function
As microdosing involves taking doses far below the standard therapeutic range, you may experience minimal or no noticeable benefits
